miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy

SIMPLE SUMMARY: Cancer onset and progression are promoted by high deregulation of the immune system. Recently, major advances in molecular and clinical cancer immunology have been achieved, offering new agents for the treatment of common tumors, often with astonishing benefits in terms of prolonged...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Di Martino, Maria Teresa, Riillo, Caterina, Scionti, Francesca, Grillone, Katia, Polerà, Nicoletta, Caracciolo, Daniele, Arbitrio, Mariamena, Tagliaferri, Pierosandro, Tassone, Pierfrancesco
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036682/
https://ncbi.nlm.nih.gov/pubmed/33808190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071587
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki